Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL

NCT02419560

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of Virginia Charlottesville, Virginia, United States
View Trial Details
Completed

Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma

NCT03682796

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

NCT00070018

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
  • Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
View all 48 locations
View Trial Details
Completed

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +30 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma

NCT01412879

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 204 locations
View Trial Details

Related conditions